May 24, 2019 by Chain Drug Review
DIR fee reform, Hy-Vee, NACDS, Randy Edeker
Featured Articles, Leading Headlines, Pharmacy, Retail News
WEST DES MOINES, Iowa — Hy-Vee on Friday expressed dismay that a new Medicare rule did not provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate senior citizens’ prescription drug costs. A proposal advanced by the Centers for Medicare & Medicaid Services (CMS) and supported by Hy-Vee was not included in the final rule published on
May 17, 2019 by Chain Drug Review
DIR pharmacy reform, NACDS, NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. — The National Community Pharmacists Association and the National Association of Chain Drug Stores issued the following statement Thursday after a final drug pricing rule was released and failed to reform pharmacy direct and indirect remuneration fees, or pharmacy DIR: “We are disappointed and frustrated that this final rule fails to finalize pharmacy
April 29, 2019 by Chain Drug Review
NACDS
Videos
The 2019 NACDS Annual Meeting is happening right now in Palm Beach, Fla. Watch video highlights from yesterday’s program, featuring best-selling author and historian Doris Kearns Goodwin, and business developments during the Strategic Exchange Appointments.
March 20, 2019 by Chain Drug Review
“NACDS Optimizing Care Process Guide”, NACDS, NACDS Optimizing Care Program, Steven Anderson
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) Wednesday announced the online “NACDS Optimizing Care Process Guide,” a resource for states, pharmacies and others seeking to increase patients’ access to clinical care delivered in community pharmacies. This initiative aligns with other efforts to empower pharmacists to improve patients’ health outcomes, and with
March 19, 2019 by Chain Drug Review
Centers for Medicare & Medicaid Services’ (CMS), medicaid dispensing fees in Washington State, NACDS, National Community Pharmacists Association (NCPA), Washington State Pharmacy Association (WSPA)
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS, the Washington State Pharmacy Association (WSPA) and the National Community Pharmacists Association (NCPA) filed an important legal brief last week in support of the Centers for Medicare & Medicaid Services’ (CMS) rejection of Washington State’s below-cost reimbursement of community pharmacies providing care and services to Medicaid patients, as inconsistent with federal
March 18, 2019 by Jeffrey Woldt
NACDS, NACDS RxImpact Day
March 18, 2019, Opinion
The National Association of Chain Drug Stores mobilized an impressive array of pharmacy advocates earlier this month to inform, educate and motivate members of Congress and other federal officials about the need to support policies that enable members of the profession to serve patients effectively. The 424 pharmacy proponents — including key executives from many
March 15, 2019 by Chain Drug Review
Anderson, NACDS, opioids
Featured Articles, Leading Headlines, Pharmacy
ARLINGTON, Va.— The National Association of Chain Drug Stores Friday welcomed Senate legislation that would limit to a seven-day supply the initial prescriptions of opioids for acute pain — a move that is consistent with Centers for Disease Control and Prevention’s (CDC) guidelines. Sens. Kirsten Gillibrand (D., N.Y.) and Cory Gardner (R., Colo.) announced the
March 15, 2019 by Chain Drug Review
Arkansas Gov. Asa Hutchinson (R) signed the bill into law March 13, electronic prescribing bill (SB 174), for controlled substance prescriptions for Schedule II through Schedule VI, NACDS, Steven Anderson, which will help prevent opioid abuse
Leading Headlines, Pharmacy
ARLINGTON, Va.—The National Association of Chain Drug Stores (NACDS) praises the enactment of an electronic prescribing bill (SB 174), for controlled substance prescriptions for Schedule II through Schedule VI, which will help prevent opioid abuse. Arkansas Gov. Asa Hutchinson (R) signed the bill into law March 13, which will become effective January 1, 2021. NACDS
March 14, 2019 by Chain Drug Review
Azar, DIR fees, NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. – In a statement to the Senate Finance Committee Thursday, the National Association of Chain Drug Stores stressed the importance of finalizing Health and Human Services (HHS) secretary Alex Azar’s proposals to reform pharmacy direct and indirect remuneration (DIR) fees, and of developing a standardized pharmacy quality incentive program. “The FY2020 HHS Budget
March 8, 2019 by Chain Drug Review
DIR fee reform, NACDS, NACDS president and chief executive officer Steven Anderson
Leading Headlines, Pharmacy
ARLINGTON, Va. – Morning Consult Friday published an opinion piece by the National Association of Chain Drug Stores (NACDS) entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.” The op-ed emphasizes the threat of DIR (direct and indirect remuneration) fees and lays out the ways in which DIR fee reform will
March 7, 2019 by Chain Drug Review
NACDS, RxImpact Day on Capitol Hill, Steven Anderson
Featured Articles, Leading Headlines, Pharmacy
WASHINGTON – An impressive force of 424 advocates from all 50 states reached every Congressional office during the 2019 National Association of Chain Drug Stores (NACDS) RxIMPACT Day on Capitol Hill. Since its inception in 2009, the groundbreaking event has seen a 200% total participation increase, including representation from 60% of colleges and schools of
March 6, 2019 by Chain Drug Review
11th Annual NACDS RxIMPACT Day on Capitol Hill, NACDS
Leading Headlines
WASHINGTON — As over 400 individuals from 50 states participate Wednesday in the 11th Annual NACDS RxIMPACT Day on Capitol Hill, NACDS is calling on members to participate in its biggest letter-writing campaign ever to preserve and advance beneficiary access to pharmacy services. “You might not be with us here in Washington, but you can
March 1, 2019 by Chain Drug Review
Americans for Free Trade, NACDS, President Trump
Leading Headlines
ARLINGTON, Va. — Americans for Free Trade, a broad coalition united against tariffs, of which NACDS is a member, sent a letter this week to President Trump commending the administration for making progress on trade negotiations and recognizing the negative impact of tariffs on American businesses by avoiding a tariff hike on March 2. The coalition emphasized
March 1, 2019 by Chain Drug Review
Congressional Doctors Caucus, NACDS, National Community Pharmacists Association (NCPA), Phil Roe
Leading Headlines, Pharmacy
WASHINGTON — NACDS and the National Community Pharmacists Association (NCPA) held a briefing this week for the Congressional Doctors Caucus. The Caucus, chaired by Rep. Phil Roe (R, Tenn.), is comprised of 16 medical providers in Congress who use their medical expertise to develop patient-centered healthcare policy. NACDS and NCPA discussed the Centers for Medicare